BIFIDOBACTERIUM LONGUM NCIMB 41676
Bifidobacterium longum strain NCIMB 41676 is useful for counter-regulating social rejection/ostracism and/or for improving coping skills.
1 . Bifidobacterium longum strain NCIMB 41676 for use in counter-regulating stress responses and/or negative emotions in humans.
2 . Bifidobacterium longum strain NCIMB 41676 for use as claimed in claim 1 wherein the negative emotion is caused by social stress.
3 . Bifidobacterium longum strain NCIMB 41676 for use in counter-regulating social stress in humans.
4 . Bifidobacterium longum strain NCIMB 41676 for use in counter-regulating social rejection/ostracism in humans.
5 . Bifidobacterium longum strain NCIMB 41676 for use in improving coping skills in stressful situations in humans.
6 . Bifidobacterium longum strain NCIMB 41676 for use in counter-regulating stress responses, negative emotions, social stress, and/or social rejection/ostracism, and/or in improving coping skills in stressful situations in mammals.
7 . Bifidobacterium longum strain NCIMB 41676 for use as claimed in any of claims 1 to 6 wherein the strain is in the form of viable cells.
8 . Bifidobacterium longum strain NCIMB 41676 for use as claimed in any of claims 1 to 6 wherein the strain is in the form of non-viable cells.
9 . Bifidobacterium longum strain NCIMB 41676 for use as claimed in any of claims 1 to 8 wherein the strain is in a formulation which is suitable for oral administration or consumption.
10 . Bifidobacterium longum strain NCIMB 41676 for use as claimed in claim 9 wherein the formulation comprises a prebiotic.
11 . Bifidobacterium longum strain NCIMB 41676 for use as claimed in claim 9 or 10 wherein the formulation further comprises an ingestable carrier.
12 . Bifidobacterium longum strain NCIMB 41676 for use as claimed in claim 11 wherein the ingestable carrier is a pharmaceutically acceptable carrier such as a capsule, tablet or powder.
13 . Bifidobacterium longum strain NCIMB 41676 for use as claimed in claim 11 wherein the ingestible carrier is a food product such as an acidified milk, a yoghurt, a frozen food such as frozen yoghurt or ice cream, a gum, a candy, a milk powder, a milk concentrate, a cheese spread, a nutritional composition, a nutritional supplement, a cereal bar, a dressing or a beverage.
14 . Bifidobacterium longum strain NCIMB 41676 for use as claimed in claim 11 or 13 wherein the formulation is an infant food.
15 . Bifidobacterium longum strain NCIMB 41676 for use as claimed in any of claim 9 to 12 or 15 wherein the formulation comprises a pet food.
16 . Bifidobacterium longum strain NCIMB 41676 for use as claimed in any of claims 9 to 15 wherein the formulation comprises a protein and/or peptide, in particular proteins and/or peptides that are rich in glutamine/glutamate, a lipid, a carbohydrate, a vitamin, mineral and/or trace element.
17 . Bifidobacterium longum strain NCIMB 41676 for use as claimed in any of claims 9 to 16 wherein the strain is present in the formulation in an amount of more than 10 6 cfu.
18 . Bifidobacterium longum strain NCIMB 41676 for use as claimed in any of claims 9 to 17 wherein the strain is present in the formulation in an amount of from 10 7 to 10 10 cfu.
19 . Bifidobacterium longum strain NCIMB 41676 for use as claimed in any of claims 9 to 18 wherein the strain is present in the formulation in an amount of from 10 8 to 10 9 cfu.
20 . Bifidobacterium longum strain NCIMB 41676 for use as claimed in any of claims 7 to 19 wherein the formulation comprises an adjuvant.
21 . Bifidobacterium longum strain NCIMB 41676 for use as claimed in any of claims 7 to 20 wherein the formulation comprises a drug entity.
22 . Bifidobacterium longum strain NCIMB 41676 for use as claimed in any of claims 7 to 21 wherein the formulation comprises a biological compound.